Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Bullish +65

Aaron Wealth Advisors LLC Sells 1,377 Shares of Intuitive Surgical, Inc ...

📉 Aaron Wealth Advisors LLC cut its ISRG stake by 21.9% in Q1, selling 1,377 shares while retaining 4,903 shares valued at $2.26 million.

📈 Brighton Jones LLC increased its position by 24.9% in Q4 to own 3,672 shares worth $1.92 million.

📊 Intuitive Surgical reported Q1 revenue of $2.77 billion, a 23.0% increase compared to the same quarter last year.

💰 The company posted earnings per share of $2.50, topping analyst estimates of $2.08 by $0.42.

📉 Net margin for the quarter reached 28.15%, demonstrating strong profitability on the reported revenue.

🏦 Citigroup upgraded its rating to 'Buy' with a $590 price target, while other firms like Goldman Sachs and TD Cowen lowered targets.

📈 Institutional investors own 83.64% of the company's outstanding stock, indicating high institutional confidence.

🏢 The firm operates with a market capitalization of $141.55 billion and trades at a P/E ratio of 48.45.

📉 The stock price is currently trading near its 50-day moving average of $433.94 after hitting a twelve-month high of $603.88.

🔬 Intuitive Surgical focuses on robotic-assisted surgical systems like the da Vinci platform to improve operating room precision.

Bullish Signals
  • Intuitive Surgical reported revenue of $2.77 billion, which represents a significant 23.0% year-over-year growth.
  • The company beat earnings expectations with $2.50 EPS compared to the consensus estimate of $2.08.
  • Net margin expanded to 28.15%, highlighting strong operational efficiency and pricing power.
  • Citigroup upgraded its rating from 'neutral' to 'buy' with a price target of $590.00.
  • Institutional ownership remains high at 83.64%, suggesting sustained confidence from major investors.
  • Main Street Financial Solutions LLC significantly grew its stake by 92.4% in the second quarter.
Risk Factors
  • Several major analysts, including Leerink Partners, TD Cowen, and Goldman Sachs, recently lowered their price targets for ISRG.
  • The stock is currently trading below its 200-day moving average of $485.17, indicating some short-term weakness.
  • The PEG ratio stands at 3.27, which may suggest the stock is priced for high growth relative to its earnings expansion.
Full Analysis
Aaron Wealth Advisors LLC reduced its stake in Intuitive Surgical, Inc. (ISRG) by 21.9% in the first quarter, selling 1,377 shares and holding a remaining position of 4,903 shares valued at $2.26 million. This move was part of broader institutional activity where other firms like Brighton Jones LLC increased their holdings by 24.9%, while Sivia Capital Partners, Schnieders Capital Management, Osterweis Capital Management, and Main Street Financial Solutions also adjusted or initiated positions in the second quarter. Intuitive Surgical reported strong financial performance for the quarter ended April 21st, with revenue of $2.77 billion representing a 23.0% year-over-year increase. The company posted earnings per share of $2.50, significantly beating the consensus estimate of $2.08, and achieved a net margin of 28.15%. Analysts maintain an average rating of 'Moderate Buy' with a consensus price target of $573.42, though recent analyst actions include Citigroup upgrading to 'Buy' while Leerink Partners, TD Cowen, and Goldman Sachs lowered their price targets. The medical technology company, known for its da Vinci surgical systems, continues to operate with a market capitalization of $141.55 billion. Despite the stock trading near its 50-day moving average of $433.94, the firm's robust earnings beat and high institutional ownership of 83.64% suggest continued confidence in its robotic-assisted surgery platform. The mixed analyst price targets reflect a cautious but generally positive outlook on the company's growth trajectory.